We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cancer Therapies Derived from Marine Animals

By Biotechdaily staff writers
Posted on 05 Aug 2008
Scientists from Aberdeen, Luxembourg, and the South Pacific have studied the properties of natural products derived from animals found in Fijian waters, and demonstrated that not only many specific compounds found in these organisms have potential use in anticancer therapies, but others may also be useful for improving drug delivery, currently one of the most significant problems faced by medical researchers.

Prof. Marcel Jaspars, from the University of Aberdeen (UK), presented insights into these new compounds on July 7, 2008, at the Society for Experimental Biology's annual meeting in Marseille, France.

The investigators focused on finding compounds that interfere with a protein called nuclear factor-kappa B (NF-kB). This specific protein is known to have a crucial role in many types of cancer, as well as a number of other diseases including inflammatory bowel disease, arthritis, and asthma, so there is a major drive to find molecules which can inhibit its activity. "We have tested a large number of marine species to see which can prevent NF-kB from working,” explains Prof. Jaspars. "A few animals, including sponges, soft corals, and sea lilies, were examined further, and from these we have been able to isolate and characterize the compounds responsible. We have shown that one of these molecules is able to allow normal cell death [which NK-kB switches off in some cancerous cells] to start up again, a property which we will be going onto study in much more detail.”

There is another possible application of molecules isolated from marine creatures that has the potential to have just as great an impact on the development of new medicines. "It is an unfortunate reality that currently, many new excellent drugs are discovered that cannot be delivered effectively to the places where they are required,” Prof. Jaspars revealed. "However, we have isolated one compound from a Mediterranean sponge that may help to end this trend. This molecule can reversibly create pores in cell membranes, a property for we envisage vast possibilities in the transportation of medicinal drugs. As we can now make this compound in the lab in large quantities, we are now able to investigate possible applications of the molecule, including drug delivery into tumors, gene delivery for cystic fibrosis and delivery of drugs into the eye.”

NF-kB is a protein complex found to regulate gene expression. It is involved in immune responses to infection and has been demonstrated to play a role in many diseases including cancer, inflammatory and autoimmune diseases.


Related Links:
University of Aberdeen

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Automated Immunoassay Analyzer
SuperFlex™
All-in-One Molecular System
AIO M160

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
05 Aug 2008  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
05 Aug 2008  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
05 Aug 2008  |   BioResearch